DJ Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 26-Sep-2023 / 12:58 GMT/BST=----------------------------------------------------------------------------------------------------------------------
The Vanguard Group, Inc. Form 8.3 26-Sep-2023 / 12:58 GMT/BST =---------------------------------------------------------------------------------------------------------------------- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code 1. KEY INFORMATION Full name of discloser: The Vanguard Group, Inc.
Details of any open stock-settled derivative positions , or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 .Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE
Class of relevant Product description Exercising/ exercised security against Number of securities Exercise price per unit e.g. call option Other dealings Is a Supplemental Form 8 attached? No Date of disclosure: 26 September 2023 Contact name: Shawn Acker Telephone number*: 001-610-669-6713 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
MDAX-Papier KION GROUP-Aktie: So viel hätten Anleger an einem frühen KION GROUP-Investment verlorenBei einem frühen KION GROUP-Investment müssten Anleger so viel Verlust verbuchen.
Weiterlesen »
VERBIO Vereinigte BioEnergie Buy (Jefferies & Company Inc.) 26.09.2023 | AnalyseVERBIO Vereinigte BioEnergie Buy (Jefferies & Company Inc.) 26.09.2023 | Analyse | finanzen.net
Weiterlesen »